Outcomes of inhaled nitric oxide in preterm neonates - a five-year experience in a tertiary neonatal centre.
To review the outcome of preterm neonates treated with iNO. The neonatal electronic database was reviewed between April 1, 2009 and March 31, 2014. In the five-year period, 142 babies were treated with iNO. Forty-two preterm neonates <34(+0) weeks were included in this review. During this period, the use of iNO in preterm neonates <26(+0) weeks rose from 1.4% to 4.8% and the mortality was significantly higher in this group (69%). There is an increasing trend in using iNO as a rescue treatment in preterm neonates. The outcomes were very poor in the preterm neonates <26(+0) weeks. A cautious approach is warranted in the absence of robust evidence to support the use of iNO, in preterm neonates <26(+0) weeks.